GoodRx Holdings (GDRX) Treasury Shares (2020 - 2025)

GoodRx Holdings' Treasury Shares history runs 6 years deep, the most recent figure standing at $25.2 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 20.59% year-over-year to $25.2 million; the TTM figure through Dec 2025 stood at $25.2 million (up 20.59% YoY), while the FY2025 annual figure was $25.2 million, up 20.59% from the prior year.
• Treasury Shares came in at $25.2 million for Q4 2025 at GoodRx Holdings, up from $20.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $25.2 million in Q4 2025 to a low of $469000.0 in Q3 2022.
• A 5-year average of $9.3 million and a median of $6.2 million in 2021 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 92.39% in 2022 and soared 1736.56% in 2024, its largest moves.
• GoodRx Holdings' Treasury Shares stood at $4.4 million in 2021, then jumped by 90.84% to $8.5 million in 2022, then jumped by 41.91% to $12.0 million in 2023, then surged by 74.17% to $20.9 million in 2024, then gained by 20.59% to $25.2 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $25.2 million, $20.0 million, and $20.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison